Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03394248 · ClinicalTrials.gov registry record
The Effects of Subconcussive Events on Cognition
A clinical trial, sponsored by New York Institute of Technology.
- Completed
- Registry status
- 20
- Enrollment target
NCT03394248: Completed study, sponsored by New York Institute of Technology.
NCT03394248 is a clinical trial that has completed, run by New York Institute of Technology. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03394248 has completed, sponsored by New York Institute of Technology.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine early detection of concussion for those at risk of developing symptoms and to be able to detect subconcussive cerebral impairment, and thus gaining a better understanding of the injury patterns for concussions in Men's and Women's Collegiate sports.
Primary Outcome
A mouthguard with built in sensors to collect data above the predetermined acceleration thresholds. The predetermined threshold for acceleration will be set to 5G in order to collect more data about subconcussive impacts, in addition to concussive impacts
Interventions
- DEVICE Vector Mouthguard
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-01-26 |
| Est. Completion | 2020-03-13 |
What the finished NCT03394248 record still lists
NCT03394248 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Vector Mouthguard is the first listed.
NCT03394248 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03394248 about?
NCT03394248 is a clinical study titled "The Effects of Subconcussive Events on Cognition". The purpose of this study is to determine early detection of concussion for those at risk of developing symptoms and to be able to detect subconcussive cerebral impairment, and thus gaining a better understanding of the injury patterns for concussions in Men's and Women's Collegiate sports.
What is the current status of trial NCT03394248?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2018-01-26. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT03394248?
The interventions under investigation include: Vector Mouthguard (DEVICE).
Who is sponsoring clinical trial NCT03394248?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI